IRIS
DE STEFANO, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 40.227
EU - Europa 26.761
AS - Asia 16.001
SA - Sud America 3.033
Continente sconosciuto - Info sul continente non disponibili 916
AF - Africa 797
OC - Oceania 67
Totale 87.802
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 39.703
GB - Regno Unito 6.388
CN - Cina 5.283
IT - Italia 4.948
SG - Singapore 4.532
RU - Federazione Russa 4.401
IE - Irlanda 3.155
BR - Brasile 2.488
UA - Ucraina 2.017
HK - Hong Kong 2.012
FR - Francia 1.524
VN - Vietnam 1.381
SE - Svezia 1.360
DE - Germania 1.229
KR - Corea 853
FI - Finlandia 731
BD - Bangladesh 517
IN - India 371
ZA - Sudafrica 341
CA - Canada 252
NL - Olanda 232
AR - Argentina 192
ES - Italia 188
NG - Nigeria 169
TR - Turchia 159
IQ - Iraq 154
MX - Messico 137
PK - Pakistan 99
AT - Austria 94
BE - Belgio 92
EC - Ecuador 88
JP - Giappone 85
PL - Polonia 81
CO - Colombia 61
ID - Indonesia 60
CL - Cile 58
PH - Filippine 58
VE - Venezuela 57
AU - Australia 55
SA - Arabia Saudita 55
MA - Marocco 50
KE - Kenya 49
UZ - Uzbekistan 44
CZ - Repubblica Ceca 36
DZ - Algeria 36
RO - Romania 35
CI - Costa d'Avorio 34
IR - Iran 34
PY - Paraguay 34
AE - Emirati Arabi Uniti 33
NP - Nepal 32
CH - Svizzera 31
IL - Israele 31
EG - Egitto 29
TN - Tunisia 29
JM - Giamaica 28
JO - Giordania 27
MK - Macedonia 26
AZ - Azerbaigian 24
EU - Europa 23
KZ - Kazakistan 22
MY - Malesia 20
PE - Perù 20
UY - Uruguay 20
LT - Lituania 19
RS - Serbia 19
GR - Grecia 17
BG - Bulgaria 16
HN - Honduras 16
AL - Albania 14
MD - Moldavia 14
PT - Portogallo 14
DO - Repubblica Dominicana 13
SN - Senegal 13
CR - Costa Rica 12
HU - Ungheria 12
OM - Oman 12
SY - Repubblica araba siriana 12
NZ - Nuova Zelanda 11
PS - Palestinian Territory 11
TH - Thailandia 11
BO - Bolivia 10
LB - Libano 10
TT - Trinidad e Tobago 10
KG - Kirghizistan 9
BY - Bielorussia 8
CG - Congo 8
DK - Danimarca 8
GT - Guatemala 8
BH - Bahrain 7
ET - Etiopia 7
HR - Croazia 7
NO - Norvegia 7
PA - Panama 7
PR - Porto Rico 7
SC - Seychelles 7
SV - El Salvador 7
BB - Barbados 6
GE - Georgia 6
LU - Lussemburgo 6
Totale 86.788
Salva come PNG Salva come JPEG
Città #
Southend 5.637
Dallas 4.668
Fairfield 4.003
Dublin 3.138
Houston 3.074
Ashburn 2.895
Singapore 2.414
Chandler 1.954
Woodbridge 1.918
Jacksonville 1.664
Seattle 1.589
Wilmington 1.587
Milan 1.460
Cambridge 1.390
Hong Kong 1.327
Menlo Park 1.283
Santa Clara 1.242
San Jose 1.179
Beijing 1.150
Council Bluffs 1.125
Moscow 1.088
Hefei 1.057
Seoul 843
Princeton 753
Ann Arbor 708
The Dalles 635
Nanjing 559
Siena 508
Rome 493
Los Angeles 466
Ho Chi Minh City 420
Lauterbourg 381
Hanoi 361
New York 326
Columbus 324
Helsinki 299
Johannesburg 296
Boardman 284
San Mateo 258
Buffalo 248
São Paulo 223
San Diego 219
Nanchang 212
Florence 171
Shenyang 162
Abuja 161
Munich 146
Málaga 117
Dong Ket 113
Norwalk 112
London 107
Orem 102
Tianjin 102
Bengaluru 97
Turin 96
Figino 94
Hebei 94
Changsha 92
Chicago 88
Frankfurt am Main 87
Redondo Beach 83
Shanghai 82
Jiaxing 78
Lancaster 78
Düsseldorf 77
Kunming 77
Amsterdam 76
San Francisco 73
Toronto 72
Rio de Janeiro 69
Brussels 68
Dearborn 68
Brooklyn 66
Chennai 64
Jinan 62
Naples 62
Tokyo 62
Falls Church 61
Belo Horizonte 60
Warsaw 60
Phoenix 59
Turku 59
Montreal 58
Baghdad 57
Guangzhou 57
Vienna 57
Hangzhou 56
Lappeenranta 55
Brasília 54
Izmir 54
Palermo 53
Nuremberg 52
Atlanta 51
Boston 51
Haiphong 51
Stockholm 51
Curitiba 50
Zhengzhou 50
Bologna 47
Mexico City 47
Totale 60.066
Salva come PNG Salva come JPEG
Nome #
Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients 801
Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. 595
A novel NOTCH3 frameshift deletion and mitochondrial abnormalities in a patient with CADASIL 494
An atypical case of Creutzfeldt-Jakob disease mimicking frontotemporal dementia: genotypic influence and clinical implications 487
Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis 486
Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis 459
A new missense mutation in caveolin-3 gene causes rippling muscle disease. 408
A rare association of myasthenia gravis and mitochondrial myopathy: a clinical, biochemical and morphologic study of one case 384
A Rett syndrome MECP2 mutation that causes mental retardation in men 379
A new family with CADASIL: presentation of an homozygous patient and comparison with heterozigous phenotypes. 365
Hemodynamic evaluation of the optic nerve head in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. 364
1H-MR Spectroscopy in Traumatic Brain Injury 357
Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures 352
Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment 351
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: Update on clinical, diagnostic, and management aspects 346
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 331
The burden of microstructural damage modulates cortical activation in elderly subjects with MCI and leuko-araiosis. A DTI and fMRI study 331
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes 320
A human post-mortem brain model for the standardization of multi-centre MRI studies 316
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis 305
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study 305
A case of ovarioleukodystrophy without elF2B mutations 300
A novel approach with “skeletonised MTR” measures tract-specific microstructural changes in early primary-progressive MS 300
Acute unilateral visual loss as the first symptom of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 298
Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis 293
Peak width of skeletonized mean diffusivity (PSMD) as marker of widespread white matter tissue damage in multiple sclerosis 290
[(11)C]PBR28 or [(18)F]PBR111 detect white matter inflammatory heterogeneity in multiple sclerosis 289
Diffuse brain damage in normal tension glaucoma 289
SIENA-XL for improving the assessment of gray and white matter volume changes on brain MRI 289
Vitamin D in neurological diseases 287
Primary Progressive Multiple Sclerosis Evolving from Radiologically Isolated Syndrome 286
The role of dentate nuclei in human oculomotor control: Insights from cerebrotendinous xanthomatosis 285
Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities 282
Systemic blood pressure profile in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 281
Clinical Course of Two Italian Siblings with Ataxia-Telangiectasia-Like Disorder. 279
A semiautomatic method for multiple sclerosis lesion segmentation on Dual-Echo MR imaging: Application in a multicenter context 277
Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) 276
Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders 271
Gray matter atrophy cannot be fully explained by white matter damage in patients with MS 269
Assessing response to interferon-β in a multicenter dataset of patients with MS 264
The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI) 264
Toscana itaca (Italian CADASIL) registry: an implementable online database for CADASIL (Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy). 263
Automated identification of brain new lesions in multiple sclerosis using subtraction images 263
Blood–brain barrier permeability in a patient with Labrune syndrome due to SNORD118 mutations 263
Evidence of diffuse damage in frontal and occipital cortex in the brain of patients with post-traumatic stress disorder 262
Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis 260
2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis 258
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 258
Pronounced structural and functional damage in early adult pediatric-onset multiple sclerosis with no or minimal clinical disability 257
Association of MRI metrics and cognitive impairment in radiologically isolated syndromes 257
Structural and metabolic damage in brains of patients with SPG11-related spastic paraplegia as detected by quantitative MRI 257
Chemical pathology of acute demyelinating lesions and its correlation with disability 256
A Novel Mutation in the Notch3 Gene in an Italian Family with CADASIL: Genetic and MRI Spectroscopic Findings 255
CADASIL and cerebrovascular diseases 254
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets. 254
Brain atrophy assessment in multiple sclerosis: importance and limitations 253
DTI-derived indexes of brain WM correlate with cognitive performance in vascular MCI and small-vessel disease. A TBSS study 253
Serial KL-6 measurements in COVID-19 patients 253
Genetic leukoencephalopaties with unknown metabolic pathogenesis 252
Adult-onset Niemann-Pick type C disease: a clinical, neuroimaging and molecular genetic study 251
Merosin positive congenital muscular dystrophy with severe involvement of the central nervous system 250
Twelve-year monitoring of a patient with megalencephalic leukoencephalopathy with subcortical cysts 250
A practical review of the neuropathology and neuroimaging of multiple sclerosis 250
Relevance of brain lesion location to cognition in relapsing multiple sclerosis 250
Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis 249
Acute visual loss due to anterior ischemic optic neuropathy as first symptom in a patient with CADASIL 248
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery 248
Structural and functional brain changes beyond visual system in patients with advanced glaucoma 247
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome 246
Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients 246
Altered Large-Scale Brain Functional Connectivity in Ocular Hypertension 246
A comparison of cognitive performances between multiple sclerosis patients with pediatric- versus adult onset disease 245
Fingolimod effect on brain volume loss independently contributes to its effect on disability 244
A multicentre study of motor functional connectivity changes in patients with multiple sclerosis 244
Optic atrophy in Marinesco-Sjögren syndrome: an additional ocular feature. Report of three cases in two families 243
Acute metabolic brain changes following traumatic brain injury and their relevance to clinical severity and outcome. 243
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. 243
CCDC78: Unveiling the Function of a Novel Gene Associated with Hereditary Myopathy 242
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis 242
Early changes of brain connectivity in primary open angle glaucoma 241
Cortical lesions in radiologically isolated syndrome. 239
Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: A large-scale, multicentre study 239
Early structural changes in individuals at risk of familial Alzheimer's disease. A volumetry and magnetization transfer MR imaging study 239
The spectrum of magnetic resonance findings in cerebrotendinous xanthomatosis: redefinition and evidence of new markers of disease progression 238
Scoring treatment response in patients with relapsing multiple sclerosis 237
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies 236
Pathogenesis of multiple sclerosis: Insights from molecular and metabolic imaging 236
Long-term assessment of no evidence of disease activity in relapsing-remitting MS 235
Prognostic biomarkers of IFNb therapy in multiple sclerosis patients 235
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS 235
Impairment of muscle mitochondrial oxidative metabolism in McArdles's disease 233
Right-to-left shunt in CADASIL patients: prevalence and correlation with clinical and MRI findings 233
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study 233
Deep gray matter volume loss drives disability worsening in multiple sclerosis 232
Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis 230
MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis. 228
Prominent brain axonal damage and functional reorganization in "pure" adrenomyeloneuropathy. 228
Progression of regional grey matter atrophy in multiple sclerosis 227
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 225
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults 225
Totale 28.664
Salva come PNG Salva come JPEG
Categoria #
all - tutte 263.861
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 263.861
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.921 0 718 429 298 259 203 316 174 264 528 663 1.069
2022/20236.907 437 358 820 999 695 1.432 113 632 830 176 257 158
2023/20244.219 228 129 336 134 120 1.199 1.510 148 27 64 48 276
2024/202511.415 313 541 794 1.169 1.053 464 392 815 836 579 1.170 3.289
2025/202628.015 2.181 4.068 3.782 2.551 4.088 1.058 2.914 848 1.013 1.433 1.097 2.982
2026/20272.486 1.575 911 0 0 0 0 0 0 0 0 0 0
Totale 87.802